Establishment method of fingerprint spectrum of Xuezhi granules and fingerprint spectrum of Xuezhi granules
By establishing the fingerprint mapping method of Xuesusheng particles, using high-performance liquid chromatography and specific chromatography conditions, the overall evaluation problem of quality control of Xuesusheng particles is solved, and the stability and controllability of product quality is achieved, and the simplification of product quality is achieved. The inspection process is reduced and the cost is reduced.
Patent Information
- Application Number
- CN202411108180.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-08-13
AI Technical Summary
The existing technology lacks the overall evaluation standards for quality control of blood speed granules, resulting in unstable product quality and difficulty in achieving strict quality monitoring. The detection method is costly, complex in operation, and poor applicability.
Establish a fingerprint mapping method for Xuesusheng particles, determine the test product solution and reference solution of multiple batches of products through high-performance liquid chromatography, set up specific chromatographic conditions, generate a control fingerprint map, and judge product quality through similarity analysis.
It realizes the stability and controllability of the quality of the blood-speed particles, which is simple and reliable, has high precision and good repeatability, and can fully and effectively control the product quality as a whole.
Smart Images

Figure CN118980762A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of traditional Chinese medicine preparation analysis, and particularly relates to a method for establishing a fingerprint spectrum of Xuesusheng granules and the fingerprint spectrum thereof. Background Art
[0002] The formula of Xuesusheng Granules is: Chinese Angelica, Astragalus, Epimedium, Millettia reticulata, donkey-hide gelatin and hawthorn. In addition to the above main ingredients, Xuesusheng Granules also contain auxiliary materials such as sucrose and dextrin, which help to shape the drug and improve its taste. The function of Xuesusheng Granules is mainly to invigorate qi and warm yang, nourish blood and activate blood circulation. It is suitable for anemia caused by qi and blood deficiency and various bleeding diseases. It can be used to treat malnutrition anemia, iron deficiency anemia, rehabilitation after blood loss, abortion, postpartum blood supplement, adjuvant treatment after tumor radiotherapy and chemotherapy, and rehabilitation medicine after various surgeries.
[0003] Currently, there is no method for detecting the content of effective ingredients in Xuesusheng Granules in various standards, and its quality standards are not included in the pharmacopoeia. The prescription and quality standards of Xuesusheng Granules are only included in Volume 17 of the Chinese Medicine Formula Preparations in the drug standards. However, the quality standard is low and there is no detection method to control the content. In addition, Xuesusheng Granules have many flavors and complex ingredients. The analysis of individual ingredients is somewhat one-sided. It is not enough to characterize and control only one or two chemical components, and it is difficult to fully reflect the information of the drug. The dosage of precious medicinal materials cannot be strictly evaluated and controlled, which is not conducive to the quality control of Xuesusheng Granules.
[0004] A search was conducted on the domestic literature reports on the determination of multiple indexes of Xuesusheng. Among them, "Quality evaluation of Xuesusheng granules based on HPLC multi-index component combined with chemometrics [J]. Modern Drugs and Clinics, 2022, 37(11)" used high performance liquid chromatography to simultaneously determine the content of 10 components and established a quality evaluation method for Xuesusheng granules. However, the article required the use of dual wavelength for quality control, which had high requirements for instrumentation and facilities. Its reference substances included baohuoside I, vitexin, icariin, calycosin glucoside, vitexin glucoside, and vitexin. The purchase cost of 10 reference substances, such as rhamnoside, is high and difficult to obtain. For testing the overall quality of the drug, the cost is relatively high. Moreover, the 10 reference substances need to be accurately weighed and prepared, which is complicated and labor-intensive. Among the detection indicators in this document, the contents of 8 components are very low (less than 0.1%), which poses a great risk to the quality standard control in the actual production process. The contents of some components may be lower than the detection limit due to different batches of medicinal materials or slight fluctuations in the production environment, resulting in unqualified product quality, which is not conducive to quality monitoring in the actual production process and has poor production applicability.
[0005] In order to carry out research on improving the quality standards of Xuesusheng Granules, gradually improve its quality control standards, and enhance product quality and market competitiveness, it is necessary to construct a characteristic fingerprint map of Xuesusheng Granules to comprehensively evaluate the quality of Xuesusheng Granules, analyze the ingredients with higher content in the product, and implement stricter quality control of different batches of Xuesusheng Granules to ensure product quality and efficacy. Summary of the invention
[0006] 1. Technical issues to be resolved
[0007] In view of the above-mentioned shortcomings and deficiencies of the prior art, the present invention provides a method for establishing a fingerprint spectrum of Xuesusheng granules and its fingerprint spectrum, which solves the problem that the existing quality control of Xuesusheng granules lacks an overall evaluation standard, and can effectively ensure the stability, consistency and controllability of the quality of Xuesusheng granules.
[0008] (II) Technical solution
[0009] In a first aspect, the present invention provides a method for establishing a fingerprint spectrum of Xuesusheng granules, comprising the following steps:
[0010] S1. Prepare test solution and reference solution:
[0011] Test solution: Grind several batches of Xuesusheng granules, accurately quantify them, and dissolve them in 50% methanol to obtain a clear test solution;
[0012] Reference solution: Take the icariin reference substance, accurately quantify it, and then add 50% methanol to dissolve it to obtain the icariin reference solution;
[0013] S2. Set up HPLC conditions:
[0014] The chromatographic column uses octadecylsilane bonded silica gel as filler, the detection wavelength is 270nm; the flow rate is 0.8-1.2ml / min; the column temperature is 25-35℃; the mobile phase A is acetonitrile, the mobile phase B is 0.2% formic acid solution, and gradient elution is performed, and the volume ratio of the mobile phases A and B changes from 0 to 25min, A:B is 2%:98%→5%:95%; 25 to 35min, A:B is 5%:95%→10%:90%; 35 to 80min, A:B is 10%:90%→30%:70%; 80 to 100min, A:B is 30%:70%→35%:65%; 100 to 125min, A:B is 35%:65%→60%:40%;
[0015] Accurately pipette 5-20 μl of the test solution and reference solution of multiple batches of Xuesusheng granules respectively, inject into high performance liquid chromatograph, measure, and obtain liquid chromatograms of the test solution and reference solution respectively;
[0016] S3. Establish the fingerprint of Xuesusheng Granules: import the liquid chromatograms of test sample solutions from different batches into the similarity evaluation system of traditional Chinese medicine chromatographic fingerprint, select the chromatographic peaks common to the test samples in each batch to generate a control fingerprint of Xuesusheng Granules, and determine the icariin peak on the control fingerprint by comparing with the peaks of the reference solution. Taking the icariin peak as the reference peak, calculate the relative peak areas and relative retention times of the remaining common peaks.
[0017] According to a preferred embodiment of the present invention, in S1, the test solution is prepared by grinding the Xuesusheng granules into powder, dissolving them in 50% methanol after precise quantification to obtain a clear solution with a concentration of 0.05-1 g / mL;
[0018] Preparation of reference solution: Take icariin reference substance, accurately quantify it, and then dissolve it in methanol to obtain 30-80 μg / mL icariin reference solution.
[0019] According to a preferred embodiment of the present invention, in S1, the test solution is prepared as follows: the Xuesusheng granules are taken, ground, accurately weighed, placed in a stoppered conical flask, and 12.5 mL of 50% methanol is accurately added for every 1 g of Xuesusheng granules to dissolve, ultrasonically treated, cooled, and the lost weight is supplemented with 50% methanol, shaken, filtered, and the filtrate is obtained.
[0020] For example, take 2g of Xuesusheng granules, grind them into powder, weigh them accurately, put them in a stoppered conical flask, accurately add 25ml of 50% methanol, weigh them, treat them with ultrasound (power 400W, frequency 50kHz) for 30min, let them cool, weigh them again, make up the lost weight with 50% methanol, shake them well, filter them, and take the filtrate to obtain the product.
[0021] According to a preferred embodiment of the present invention, in S1, the reference solution is prepared by taking an appropriate amount of icariin reference substance, accurately weighing it, and adding 50% methanol to prepare a solution containing 50 μg per 1 ml.
[0022] According to a preferred embodiment of the present invention, in S2, the chromatographic column is an Agilent 5TC-C18 column, with an inner diameter×length of 4.6×250 mm and a filling particle size of 5 μm.
[0023] According to a preferred embodiment of the present invention, in S2, the HPLC conditions are: detection wavelength is 270 nm; flow rate is 1 ml / min; column temperature is 30° C.; injection volume is 10 μl.
[0024] According to a preferred embodiment of the present invention, in S3, the control fingerprint of Xuesusheng granules contains 12 common peaks, and the peak numbers are marked in order of peak appearance time. By comparing with the peaks of the reference solution, peak No. 10 on the control fingerprint is determined to be the icariin peak. Taking peak No. 10 as the reference peak, the relative peak areas and relative retention times of the remaining common peaks are calculated.
[0025] In a second aspect, the present invention provides a fingerprint of Xuesusheng granules, which comprises: 12 peaks, wherein peak 10 is icariin, and its relative retention time is 1.0000, and its relative peak area is 1.0000; the remaining peaks are: peak 1 with a relative retention time of 0.1451 and a relative peak area of 1.3846, peak 2 with a relative retention time of 0.1634 and a relative peak area of 0.4481, peak 3 with a relative retention time of 0.5201 and a relative peak area of 0.0600, peak 4 with a relative retention time of 0.5889 and a relative peak area of 0.2607, peak 5 with a relative retention time of 0.7 048 and relative peak area of peak 5, peak 5 with relative retention time of 0.8174 and relative peak area of 0.2565, peak 6 with relative retention time of 0.9592 and relative peak area of 0.1436, peak 8 with relative retention time of 0.9707 and relative peak area of 0.1958, peak 9 with relative retention time of 0.9830 and relative peak area of 1.9460, peak 11 with relative retention time of 1.3227 and relative peak area of 0.2826, peak 12 with relative retention time of 1.3626 and relative peak area of 0.0753.
[0026] In a third aspect, the present invention provides a method for evaluating the quality of Xuesusheng granules, comprising: taking a batch of Xuesusheng granules, preparing a test solution according to the preparation method of the test solution, accurately aspirating the test solution and injecting it into a high performance liquid chromatograph for measurement to obtain liquid chromatograms of the test solutions; performing similarity analysis on the liquid chromatograms and the fingerprints of the above-mentioned Xuesusheng granules, and when the similarity is ≥0.90, the quality of the batch of products is judged to be qualified, otherwise it is judged to be unqualified.
[0027] It can be understood by those skilled in the art that when evaluating the product quality of a batch of Xuesusheng granules, the preparation method of the test solution of the batch of products refers to the preparation method of the test solution, and the chromatographic conditions refer to the high performance liquid chromatography conditions when the fingerprint spectrum is established.
[0028] (III) Beneficial effects
[0029] The technical effects of the present invention include:
[0030] (1) The method for establishing the fingerprint spectrum of Xuesusheng granules established by the present invention is simple and reliable, with high stability and precision and good repeatability.
[0031] (2) The present invention established a fingerprint of Xuesusheng Granules, calibrated 12 common peaks, and confirmed one common characteristic peak, namely Peak 10, by comparing with the chromatographic peaks of a reference solution of icariin. Peak 10 was used as the reference peak to determine the relative retention time and relative peak area of the remaining 11 common peaks.
[0032] (3) The fingerprint spectrum constructed by the present invention is used for quality monitoring of Xuesusheng Granules, which can comprehensively and effectively control the quality of Xuesusheng Granules as a whole, thereby ensuring the stability, reliability and safety of the product. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 The HPLC spectra of 10 batches of Xuesusheng granules.
[0034] Figure 2 This is the HPLC fingerprint of the Xuesusheng granules established in the present invention. DETAILED DESCRIPTION
[0035] In order to better explain the present invention and facilitate understanding, the present invention is described in detail below in conjunction with the accompanying drawings through specific implementation methods. The instruments and reagents used in the following embodiments are as follows:
[0036] 1. Instrument
[0037] Vanquish Core high performance liquid chromatograph; Agilent 5TC-C18 (4.6×250 mm, 5 μm) chromatographic column; JA5003N high precision analytical balance; XSR-105DU analytical balance; KS-250E ultrasonic cleaner.
[0038] 2. Drugs and reagents
[0039] Drugs and reagents used in the following examples: Xuesusheng granules were provided by Hebei Yongfeng Pharmaceutical Co., Ltd. with batch numbers of 07823030112, 07823050112, 07823060112, 07823070112, 07823090112, 07823100112, 07824010112, 07824040112, 07824040212, 07824040312. Icariin (110737-202017) was purchased from China Food and Drug Administration. Acetonitrile was chromatographically pure; methanol and formic acid were analytically pure.
[0040] Example 1
[0041] This embodiment provides a method for establishing a fingerprint spectrum of Xuesusheng granules, and the steps are as follows:
[0042] (1) Preparation of test solution: Take 10 batches of Xuesusheng granules, grind them into powder, accurately weigh 2 g of each batch, place them in a stoppered conical flask, accurately add 25 ml of 50% methanol, weigh the weight, ultrasonically treat (power 400 W, frequency 50 kHz) for 30 min, let cool, weigh again, make up the lost weight with 50% methanol, shake well, filter, and take the filtrate to obtain the test solution of 10 batches of Xuesusheng granules.
[0043] (2) Preparation of reference solution: Take an appropriate amount of icariin reference substance, weigh it accurately, and add 50% methanol to make a solution containing 50 μg per 1 ml.
[0044] (3) Determination: Accurately pipette the test solution and the reference solution respectively, inject them into the high performance liquid chromatograph, perform the determination, and record the chromatogram. The chromatographic conditions are as follows:
[0045] Chromatographic column: Agilent 5TC-C18 column (4.6×250mm, 5μm); detection wavelength: 270nm; flow rate: 1.0ml / min; column temperature: 30°C; injection volume: 10μl; mobile phase A: acetonitrile, mobile phase B: 0.2% formic acid solution, gradient elution was adopted, and the gradient elution method was as follows (the following % refers to volume percentage):
[0046] Time (minutes) Mobile phase A (%) Mobile phase B (%) 0~25 2→5 98→95 25~35 5→10 95→90 35~80 10→30 90→70 80~100 30→35 70→65 100~125 35→60 65→40
[0047] (4) Construction of fingerprint of Xuesusheng granules: The chromatograms of 10 batches of Xuesusheng granules were introduced into the similarity evaluation system of traditional Chinese medicine chromatographic fingerprints, and the common chromatographic peaks of each batch of Xuesusheng granules were selected. The median method was used to generate the control fingerprint (R) (e.g. Figure 1 As shown in Figure 2, the reference fingerprint contains 12 common peaks. The reference fingerprint is calibrated with peaks 1 to 12 in the order of peak appearance. By comparing the peaks of the reference fingerprint with those of the reference solution (icariin), peak 10 is determined to be the characteristic peak of icariin. Peak 10 is used as the reference peak (the relative retention time of the reference peak is 1.0000, and the relative peak area is 1.0000), and the relative peak areas and relative retention times of the remaining 11 common peaks are calculated to obtain the following: Figure 2 The HPLC fingerprint of Xuesusheng granules is shown. The relative retention times and peak areas of the 12 peaks in the HPLC fingerprint are as follows:
[0048] Relative retention time of peaks 1-12:
[0049] Peak 1 0.1451; Peak 2 0.1634; Peak 3 0.5201; Peak 4 0.5889;
[0050] Peak 5: 0.7048; Peak 6: 0.8174; Peak 7: 0.9592; Peak 8: 0.9707;
[0051] Peak 9 0.9830; Peak 10 (S) 1.0000; Peak 11 1.3227; Peak 12 1.3626;
[0052] Relative peak areas of peaks 1-12:
[0053] Peak 1: 1.3846; Peak 2: 0.4481; Peak 3: 0.0600; Peak 4: 0.2607;
[0054] Peak 5: 0.4933; Peak 6: 0.2565; Peak 7: 0.1436; Peak 8: 0.1958;
[0055] Peak No. 9 is 1.9460; Peak No. 10 (S) is 1.0000; Peak No. 11 is 0.2826; Peak No. 12 is 0.0753.
[0056] (5) The similarity of the fingerprints of 10 batches of Xuesusheng Granules was evaluated using the “Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System Research Version (2012A)”. The similarities were all greater than 0.90. The results are shown in Table 1.
[0057] Table 1: Similarity of 10 batches of blood-speed granules
[0058]
[0059] Example 2
[0060] In this example, the measurement wavelengths in step (3) are adjusted to 210 nm, 240 nm, 270 nm, 310 nm, and 350 nm, respectively. The remaining conditions are similar to those in Example 1. After HPLC detection, the number of chromatographic peaks in the chromatogram of the test solution is shown in Table 2.
[0061] Table 2: Number of chromatographic peaks at different test wavelengths
[0062]
[0063] As shown in Table 2, the number of chromatographic peaks obtained at wavelengths of 210 nm and 270 nm is the largest (10 chromatographic peaks), and when the detection wavelength is 270 nm, the chromatographic peak response value is higher and the baseline is more stable, so 270 nm is selected as the detection wavelength.
[0064] In this example, the mobile phase in step (3) was adjusted to methanol-water, acetonitrile-water, acetonitrile-0.1% formic acid solution, methanol-0.2% formic acid solution, and acetonitrile-0.2% formic acid solution, respectively. The remaining conditions were referred to Example 1 for HPLC detection. The number of chromatographic peaks in the chromatogram of the test solution is shown in Table 3.
[0065] Table 3: Number of peaks detected in different mobile phase systems
[0066]
[0067] As shown in Table 3, the number of chromatographic peaks obtained when methanol-0.2% formic acid solution and acetonitrile-0.2% formic acid solution are used as mobile phases is the largest (12 chromatographic peaks), while when acetonitrile-0.2% formic acid solution is used as mobile phase, the chromatographic baseline is more stable and the separation between peaks is better, so acetonitrile-0.2% formic acid solution is selected as mobile phase.
[0068] In this example, the mobile phase in step (3) is adjusted respectively. The adjustment conditions are as follows. The remaining conditions are determined by HPLC according to the conditions in Example 1, and then a suitable mobile phase ratio is selected.
[0069] Mobile phase conditions 1
[0070]
[0071]
[0072] The experiment was carried out according to mobile phase condition 1. The chromatogram showed that the main peaks were mostly concentrated in the first ten minutes, and the peak separation was poor.
[0073] Mobile phase conditions 2
[0074] Time (minutes) Mobile phase A (%) Mobile phase B (%) 0~5 2→5 98→95 5~15 5→10 95→90 15~30 10→30 90→70 30~50 30→35 70→65 50~60 35→60 65→40
[0075] When the experiment was carried out according to mobile phase condition 2, the separation of each chromatographic peak did not meet the requirements and the baseline of the chromatogram was uneven.
[0076] Mobile phase conditions 3
[0077] Time (minutes) Mobile phase A (%) Mobile phase B (%) 0~25 2→5 98→95 25~35 5→10 95→90 35~80 10→30 90→70 80~100 30→35 70→65 100~125 35→60 65→40
[0078] The experiment was carried out according to mobile phase condition 3. The separation of each chromatographic peak was good, the chromatogram baseline was stable, and the peak shape of each main peak was good. In summary, mobile phase condition 3 was selected as the chromatographic condition for the fingerprint of Xuesusheng particles.
[0079] Example 3
[0080] Take a test solution of a batch of Xuesusheng granules product and inject it continuously for 6 times according to the chromatographic conditions of Example 1. Determine the retention time and peak area respectively. Take the icariin peak No. 10 as the reference peak, calculate the relative retention time and relative peak area of each common peak and the reference peak, and calculate the RSD value. The results are shown in Table 4-5.
[0081] Table 4: Relative retention time of common peaks
[0082]
[0083]
[0084] Table 5: Relative peak areas of common peaks
[0085]
[0086] It can be seen from Tables 4 and 5 that the relative peak area RSD% of each common peak is less than 5%, and the relative retention time RSD% is less than 5%, indicating that the chromatographic determination conditions determined in Example 1 have good precision.
[0087] Example 4
[0088] Take the test solution of the same batch of Xuesusheng Granules products, prepare the test solution in the manner of Example 1, and measure it at 0, 2, 4, 8, 12, 18, and 24 h according to the chromatographic conditions of Example 1, and use the peak No. 10 icariin peak as the reference peak to calculate the relative retention time and relative peak area of each common peak and the reference peak, and calculate the RSD value. The results are shown in Tables 6-7.
[0089] Table 6: Relative retention time of common peaks
[0090]
[0091] Table 7: Relative peak areas of common peaks
[0092]
[0093]
[0094] It can be seen from Tables 6 and 7 that for the test solutions of the same batch of Xuesusheng Granules, when measured at 0, 2, 4, 8, 12, 18, and 24 h, the relative peak area RSD% of each common peak was <5%, and the relative retention time RSD% was <5%, indicating that the test solutions were measured at different times within 24 h according to the fingerprint establishment conditions determined in Example 1, and the measurement results were stable.
[0095] Example 5
[0096] Take the same batch of Xuesusheng granules sample, and prepare 6 test solutions according to the test solution preparation method of Example 1. Perform injection measurement according to the chromatographic conditions of Example 1 to obtain a high performance liquid chromatogram. Taking the peak No. 10 icariin peak as the reference peak, calculate the relative retention time and relative peak area of each common peak and the reference peak, and calculate the RSD value. The results are shown in Tables 8-9.
[0097] Table 8: Relative retention time of common peaks
[0098]
[0099] Table 9: Relative peak areas of common peaks
[0100]
[0101]
[0102] It can be seen from Tables 8 and 9 that 6 test solutions were prepared from the same batch of Xuesusheng granule samples according to the test solution preparation method of Example 1. When measured according to the chromatographic conditions of Example 1, the relative peak area RSD% of each common peak of the 6 test solutions was less than 5%, and the relative retention time RSD% was less than 5%. This shows that when the measurement was performed according to the chromatographic establishment conditions determined in Example 1, the measurement results had very good repeatability.
[0103] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for establishing a fingerprint spectrum of Xuesusheng granules, characterized in that: The steps include: S1. Prepare test solution and reference solution: Test solution: Grind several batches of Xuesusheng granules, accurately quantify them, and dissolve them in 50% methanol to obtain a clear test solution; Reference solution: Take icariin reference substance, accurately quantify it, and dissolve it in 50% methanol as the reference solution; S2. Set up HPLC conditions: The chromatographic column uses octadecylsilane bonded silica gel as filler, the detection wavelength is 270nm; the flow rate is 0.8-1.2ml / min; the column temperature is 25-35℃; the mobile phase A is acetonitrile, the mobile phase B is 0.2% formic acid solution, and gradient elution is performed, and the volume ratio of the mobile phases A and B changes from 0 to 25min, A:B is 2%:98%→5%:95%; 25 to 35min, A:B is 5%:95%→10%:90%; 35 to 80min, A:B is 10%:90%→30%:70%; 80 to 100min, A:B is 30%:70%→35%:65%; 100 to 125min, A:B is 35%:65%→60%:40%; Accurately pipette 5-20 μl of the test solution and reference solution of multiple batches of Xuesusheng granules respectively, inject into high performance liquid chromatograph, measure, and obtain liquid chromatograms of the test solution and reference solution respectively; S3. Establishing the fingerprint of Xuesusheng Granules: introducing the liquid chromatograms of different batches of test sample solutions into the similarity evaluation system of traditional Chinese medicine chromatographic fingerprint, selecting the chromatographic peaks common to each batch of test sample to generate a control fingerprint of Xuesusheng Granules, and determining the icariin peak on the control fingerprint by comparing it with the peak of the reference solution, taking the icariin peak as the reference peak, and calculating the relative peak areas and relative retention times of the remaining common peaks; Preparation of reference solution: Take icariin reference substance, accurately quantify it, and then dissolve it in methanol to obtain 30-80 μg / mL icariin reference solution.
2. The establishment method according to claim 1, characterized in that: In S1, preparation of the test solution: grind the Xuesusheng granules, weigh them accurately, put them in a stoppered conical flask, add 12.5 mL of 50% methanol for every 1 g of Xuesusheng granules to dissolve them, treat with ultrasound, cool, make up the lost weight with 50% methanol, shake well, filter, and obtain the filtrate.
3. The establishment method according to claim 1, characterized in that: In S1, preparation of reference solution: take an appropriate amount of icariin reference substance, accurately weigh it, add 50% methanol to make a solution containing 50 μg per 1 ml.
4. The establishment method according to claim 1, characterized in that: In S2, the chromatographic column is an Agilent 5TC-C18 column with an inner diameter × length of 4.6 × 250 mm and a filling particle size of 5 μm.
5. The establishment method according to claim 1, characterized in that: In S2, the HPLC conditions are as follows: detection wavelength is 270 nm; flow rate is 1 ml / min; column temperature is 30° C.; injection volume is 10 μl.
6. The establishment method according to claim 1, characterized in that: In S3, the control fingerprint of Xuesusheng Granules contains 12 common peaks, and the peak numbers are marked in order of peak appearance time. By comparing with the peaks of the reference solution, Peak No. 10 on the control fingerprint is determined to be the icariin peak. Taking Peak No. 10 as the reference peak, the relative peak areas and relative retention times of the remaining common peaks are calculated.
7. A fingerprint spectrum of Xuesusheng granules, characterized in that: include: There are 12 peaks, peak 10 is icariin, with a relative retention time of 1.0000 and a relative peak area of 1.0000; the remaining peaks are: peak 1 with a relative retention time of 0.1451 and a relative peak area of 1.3846, peak 2 with a relative retention time of 0.1634 and a relative peak area of 0.4481, peak 3 with a relative retention time of 0.5201 and a relative peak area of 0.0600, peak 4 with a relative retention time of 0.5889 and a relative peak area of 0.2607, peak 5 with a relative retention time of 0.7048 and a relative peak area of 0.4 Peak 5 with a relative retention time of 933, peak 6 with a relative retention time of 0.8174 and a relative peak area of 0.2565, peak 7 with a relative retention time of 0.9592 and a relative peak area of 0.1436, peak 8 with a relative retention time of 0.9707 and a relative peak area of 0.1958, peak 9 with a relative retention time of 0.9830 and a relative peak area of 1.9460, peak 11 with a relative retention time of 1.3227 and a relative peak area of 0.2826, and peak 12 with a relative retention time of 1.3626 and a relative peak area of 0.0753.
8. A method for evaluating the quality of Xuesusheng granules, characterized in that: include: A liquid chromatogram of a solution of a batch of Xuesusheng granules is obtained; The liquid chromatography is analyzed for similarity with the fingerprint spectrum described in claim 7. When the similarity is ≥ 0.90, the quality of the batch of products is judged to be qualified, otherwise it is judged to be unqualified.
Citation Information
Patent Citations
Blood-production preparation quality test method and construction method of standard fingerprint spectrum thereof
CN103926351A
Compound haemopoietic capsule for treating aplastic anemia and preparation method thereof
CN103933203A
Detection method for fingerprint of essence and blood replenishing tablets
CN107179374A
Method for detecting fingerprint spectrum of Shengbai Koufuye
CN112014481A
Fingerprint spectrum detection method of Chinese angelica blood replenishing particle reference sample and fingerprint spectrum of Chinese angelica blood replenishing particle reference sample
CN118294580A
Cited By
Quality control method and application of double-ant capsule for clearing damp and activating collaterals
CN122430498A
